Affiliation:
1. Department of Drug Metabolism and Pharmacokinetics, Bristol Laboratories, Syracuse, New York 13201
Abstract
Ceforanide (BL-S786R) is a new, broad-spectrum, parenteral cephalosporin. Pharmacokinetic properties were determined in rats (100 mg/kg), rabbits (30 mg/kg), dogs (25 mg/kg), and humans (2 g or 30 mg/kg) and compared with equivalent single doses of cefazolin. Plasma half-lives for ceforanide and cefazolin were 1.1 and 0.5 h in the rat, 5 and 0.3 h in the rabbit, 1 and 0.8 h in the dog, and 2.6 and 2 h in humans, respectively. The slower elimination of ceforanide, as reflected by longer plasma half-life, larger area under the curve, and peak plasma concentrations, was due to slower body and renal clearances. The apparent volumes of distribution of ceforanide and cefazolin were comparable. Rats, dogs, and humans excreted 80 to 100% of the ceforanide dose in the 0- to 24-h urine; rabbits excreted only 50%. Tubular secretion constituted 50% of ceforanide renal excretion in rabbits, dogs, and humans and 90% in rats; the remainder was excreted by glomerular filtration. There was no apparent correlation between the extent of tubular secretion and degree of plasma protein binding in different species. There was no significant pharmacokinetic interaction between ceforanide and amikacin in the rat. The slower elimination kinetics of ceforanide are indicative of the potential for a longer dosing interval and more effective antibiotic therapy as compared with available cephalosporins.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference11 articles.
1. Biology data book;Altman P. L;Fed. Am. Soc. Exp. Biol.,1978
2. Barza M. V. Pinn P. Tanguay and T. Murray. 1978. Comparative nephrotoxicity of new cephalosporins and aminoglycoside alone and in combination in a rat model p. 964-966. In Walter Siegenthaler and Ruedi Luthy (ed.) Current Chemotherapy. Proceedings of the 10th International Congress of Chemotherapy vol.2- Anierican Society for Microbiology Washington D.C.
3. Kinetics of tissue penetration;Bergan T.;Scand. J. Infect. Dis.,1978
4. Gibaldi M. and D. Perrier. 1975. Pharmacokinetics. Marcel Dekker Inc. New York.
5. New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity;Grasso S.;Antimicrob. Agents Chemother.,1978